deltatrials
Terminated PHASE4 INTERVENTIONAL 1-arm NCT02721576

A Trial of CMNa Combined With Concurrent Chemoradiotherapy for Locally Recurrent ESCC

A Perspective Trial of Sodium Glycididazole Combined With Concurrent Chemoradiotherapy for Locally Recurrent Squamous Cell Esophageal Carcinoma

Sponsor: Shandong Cancer Hospital and Institute

Conditions Esophageal Neoplasms
Interventions Sodium Glycididazole
Updated 10 times since 2017 Last updated: Oct 10, 2019 Started: Jul 5, 2016 Primary completion: Jun 30, 2018 Completion: Jul 30, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

The number of enrolled cases is too small.

Other terminated trials from Shandong Cancer Hospital and Institute

See all terminations from Shandong Cancer Hospital and Institute

Other Esophageal Neoplasms trials with similar outcome

Browse all Esophageal Neoplasms trials

This PHASE4 trial investigates Esophageal Neoplasms and is currently terminated or withdrawn. Shandong Cancer Hospital and Institute leads this study, which shows 10 recorded versions since 2016 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotRecruiting~Jun 2018 – ~Mar 2019 · 9 months · monthly snapshotRecruiting~Mar 2019 – ~Jul 2019 · 4 months · monthly snapshotUnknown Status~Jul 2019 – ~Nov 2019 · 4 months · monthly snapshotTerminated~Nov 2019 – ~Jan 2021 · 14 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotTerminated~Sep 2025 – present · 10 months · monthly snapshotTerminated

Change History

10 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE4

  4. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE4

  5. Nov 2019 — Jan 2021 [monthly]

    Terminated PHASE4

    Phase: PHASE2 → PHASE4

▶ Show 5 earlier versions

  1. Jul 2019 — Nov 2019 [monthly]

    Terminated PHASE2

    Status: Unknown Status → Terminated

  2. Mar 2019 — Jul 2019 [monthly]

    Unknown Status PHASE2

    Status: Recruiting → Unknown Status

  3. Jun 2018 — Mar 2019 [monthly]

    Recruiting PHASE2

  4. Feb 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

  5. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE2

    First recorded

Jul 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Shandong Cancer Hospital and Institute
Data source: Shandong Cancer Hospital and Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations